pI: 8.7086 |
Length (AA): 470 |
MW (Da): 51668 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
109 | 338 | 2boo (A) | 22 | 241 | 48.00 | 0 | 1 | 1.36 | -1.5 |
114 | 335 | 4eug (A) | 7 | 220 | 53.00 | 0 | 1 | 1.38 | -1.65 |
189 | 296 | 2dby (A) | 76 | 205 | 32.00 | 0.3 | 0.46 | 0.457387 | 0.05 |
233 | 470 | 4uqm (A) | 16 | 243 | 46.00 | 0 | 1 | 1.13098 | -1.27 |
237 | 465 | 1okb (A) | 82 | 301 | 48.00 | 0 | 1 | 1.14383 | -1.49 |
241 | 467 | 3tr7 (A) | 7 | 224 | 54.00 | 0 | 1 | 1.16358 | -1.23 |
244 | 467 | 3uf7 (A) | 7 | 222 | 53.00 | 0 | 1 | 1.1872 | -1.53 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | ME49 merozoite. | Hehl AB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | ME49 Tachyzoite, ME49 Oocyst. | Gregory Fritz HM |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | VEG Tachyzoite, ME49 Bradyzoite. | Gregory Sibley/Greg |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Ortholog group members (OG5_127417)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G18630 | uracil DNA glycosylase |
Babesia bovis | BBOV_III006230 | uracil-DNA glycosylase family protein |
Brugia malayi | Bm1_45505 | Uracil-DNA glycosylase |
Candida albicans | CaO19.7425 | uracil-DNA-glycosylase |
Cryptosporidium hominis | Chro.70188 | uracil-DNA glycosylase |
Cryptosporidium parvum | cgd7_1590 | uracil-DNA glycosylase, putative |
Chlamydia trachomatis | CT_607 | uracil DNA glycosylase |
Dictyostelium discoideum | DDB_G0273013 | uracil glycosylase |
Dictyostelium discoideum | DDB_G0277877 | uracil glycosylase |
Escherichia coli | b2580 | uracil-DNA-glycosylase |
Echinococcus granulosus | EgrG_000855500 | uracil DNA glycosylase |
Entamoeba histolytica | EHI_178910 | uracil-DNA glycosylase, putative |
Echinococcus multilocularis | EmuJ_000855500 | uracil DNA glycosylase |
Homo sapiens | ENSG00000076248 | uracil-DNA glycosylase |
Leishmania braziliensis | LbrM.18.0540 | uracil-DNA-glycosylase, putative |
Leishmania donovani | LdBPK_180480.1 | uracil-DNA-glycosylase, putative |
Leishmania infantum | LinJ.18.0480 | uracil-DNA-glycosylase, putative |
Leishmania major | LmjF.18.0480 | uracil-DNA-glycosylase, putative |
Leishmania mexicana | LmxM.18.0480 | uracil-DNA-glycosylase, putative |
Loa Loa (eye worm) | LOAG_01467 | uracil-DNA glycosylase |
Mycobacterium leprae | ML1675c | PROBABLE URACIL-DNA GLYCOSYLASE UNG (UDG) |
Mus musculus | ENSMUSG00000029591 | uracil DNA glycosylase |
Mycobacterium tuberculosis | Rv2976c | Probable uracil-DNA glycosylase Ung (UDG) |
Mycobacterium ulcerans | MUL_1980 | uracil-DNA glycosylase |
Oryza sativa | 4337373 | Os04g0673400 |
Plasmodium berghei | PBANKA_1027700 | uracil-DNA glycosylase, putative |
Plasmodium falciparum | PF3D7_1415000 | uracil-DNA glycosylase |
Plasmodium knowlesi | PKNH_1343100 | uracil-DNA glycosylase, putative |
Plasmodium vivax | PVX_085700 | uracil-DNA glycosylase, putative |
Plasmodium yoelii | PY04457 | uracil-DNA glycosylase, putative |
Saccharomyces cerevisiae | YML021C | Ung1p |
Schistosoma japonicum | Sjp_0115290 | Uracil-DNA glycosylase, putative |
Schistosoma japonicum | Sjp_0313590 | expressed protein |
Schistosoma japonicum | Sjp_0055250 | Lamin-B2, putative |
Schistosoma japonicum | Sjp_0310640 | Lamin-L(II), putative |
Schistosoma japonicum | Sjp_0113430 | ko:K03648 uracil-DNA glycosylase, putative |
Schistosoma mansoni | Smp_158920 | uracil-DNA glycosylase |
Schmidtea mediterranea | mk4.004180.00 | Uracil-DNA glycosylase |
Trypanosoma brucei gambiense | Tbg972.10.17160 | uracil-DNA glycosylase, putative |
Trypanosoma brucei | Tb927.10.13970 | uracil-DNA glycosylase, putative |
Trypanosoma congolense | TcIL3000_10_11720 | uracil-DNA glycosylase, putative |
Trypanosoma cruzi | TcCLB.511277.330 | uracil-DNA glycosylase |
Toxoplasma gondii | TGME49_307650 | uracil-DNA glycosylase |
Theileria parva | TP02_0373 | uracil-DNA glycosylase, putative |
Trichomonas vaginalis | TVAG_320720 | uracil DNA glycosylase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.13970 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.13970 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.13970 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.13970 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b2580 | Escherichia coli | non-essential | goodall |
TGME49_307650 this record | Toxoplasma gondii | Essentiality uncertain | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.8
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | uracil-DNA glycosylase | Compounds | References |
Vaccinia virus (strain Western Reserve) (VACV) (Vaccinia virus (strainWR)) | Uracil-DNA glycosylase | Compounds | References |
5 literature references were collected for this gene.